Laurent Humeau - 26 Feb 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Scientific Officer
Signature: /s/ Laurent Humeau
Issuer symbol: INO
Transactions as of: 26 Feb 2025
Net transactions value: -$7,213
Form type: 4
Filing time: 28 Feb 2025, 18:06:00 UTC
Previous filing: 16 May 2024
Next filing: 16 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+3,855	+16%		28,192	26 Feb 2025	Direct	F1
transaction	INO	Common Stock	Tax liability	$3,136	-1,584	-5.6%	$1.98	26,608	26 Feb 2025	Direct	F2
transaction	INO	Common Stock	Options Exercise		+5,010	+19%		31,618	26 Feb 2025	Direct	F3
transaction	INO	Common Stock	Tax liability	$4,077	-2,059	-6.5%	$1.98	29,559	26 Feb 2025	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-3,855	-100%	$0.000000	0	26 Feb 2025	Common Stock	3,855		Direct	F1
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-5,010	-33%	$0.000000	10,019	26 Feb 2025	Common Stock	5,010		Direct	F3
transaction	INO	Common Stock Option	Award	$0	+27,402		$0.000000	27,402	27 Feb 2025	Common Stock	27,402	$1.94	Direct	F5
transaction	INO	Restricted Stock Unit	Award	$0	+22,098		$0.000000	22,098	27 Feb 2025	Common Stock	22,098		Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein.
F5	The vesting schedule for the 27,402 options is as follows: 13,701 shares vested on February 27, 2025 and 13,701 shares will vest on February 26, 2026.
F6	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 is as follows: 7,366 shares will vest on February 26, 2026; 7,366 shares will vest on February 26, 2027; and 7,366 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.